Lancing Devices And Equipment Global Market Report 2024

The lancing devices and equipment market size has grown rapidly in recent years. It will grow from $0.59 billion in 2023 to $0.7 billion in 2024 at a compound annual growth rate (CAGR) of 18.4%. The growth observed during the historic period can be attributed to several key factors, including the increasing prevalence of diabetes, the emphasis on patient convenience, the shift toward home-based monitoring, and the overall digitization of healthcare.

The lancing devices and equipment market size is expected to see exponential growth in the next few years. It will grow to $1.46 billion in 2028 at a compound annual growth rate (CAGR) of 20.2%. The expected growth in the forecast period can be attributed to several factors, including the ongoing diabetes epidemic, advancements in testing accuracy, the increased use of telehealth and remote monitoring, and the adoption of personalized medicine in diabetes care. Notable trends anticipated during the forecast period include the integration of continuous glucose monitoring (CGM), the development of non-invasive glucose monitoring methods, a focus on user-centered design, and the use of sustainable and eco-friendly materials in lancing device and equipment manufacturing.

The increasing prevalence of diabetes is a driving force behind the lancing devices and equipment market, as more individuals rely on these devices to monitor their blood glucose levels. Lancing devices are essential tools for diabetics to collect blood samples for glucose level testing. According to the International Diabetes Federation, in 2021, approximately 537 million adults had diabetes, and this number is expected to reach 783 million by 2045. This growing population of diabetic patients is projected to fuel the demand for lancing devices and equipment, thereby promoting market growth.

The primary products in the category of lancing devices and equipment include safety lancets and standard lancets. Safety lancets are sterile, single-use devices designed for the collection of capillary blood samples. These lancing devices and equipment come in both reusable and disposable variations and are available in various penetration depths, including 0.8mm-1mm, 1.1mm-1.5mm, 1.6mm-2.0mm, and others. The end-users for these devices encompass hospitals and clinics, homecare and home diagnostics, diagnostic centers and medical institutions, research and academic laboratories, as well as various other healthcare settings.

The lancing devices and equipment market research report is one of a series of new reports that provides lancing devices and equipment market statistics, including lancing devices and equipment industry global market size, regional shares, competitors with a lancing devices and equipment market share, detailed lancing devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the lancing devices and equipment industry. This lancing devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growth of the lancing devices and equipment market is expected to be propelled by the increasing geriatric population. The geriatric population consists of older individuals, typically aged 65 and above. Lancing devices and equipment are particularly valuable for elderly individuals with diabetes who require regular blood sugar monitoring. These devices are easy to use, minimize discomfort, offer customizable depth settings, and incorporate safety features. For example, a report published by the World Health Organization (WHO) in October 2022 stated that by 2030, one in six people globally is expected to be 60 years or older. By 2050, the worldwide population of individuals aged 60 and older is estimated to reach 2.1 billion. The number of individuals aged 80 and above will increase by 426 million between 2020 and 2050 compared to the current population. Therefore, the expanding geriatric population is a significant driver of the lancing devices and equipment market's growth.

Recalls of defective lancing devices act as a constraint on the lancing devices and equipment market. Product recalls are initiated by manufacturers or regulatory bodies as a precautionary measure when safety issues or defects that could jeopardize consumer safety are identified. Lancing devices and equipment penetrate the skin and come into direct contact with blood inside the body. Any defect in these products can introduce infection into the bloodstream, posing a risk to the patient's life. For instance, the ACCU-CHECK FastClix Lancing Device by Roche Diagnostics Operations Inc. was recalled by the Food and Drug Administration (FDA) due to the lancet needle's failure to retract completely into the lancet drum as intended. Such recalls discourage product usage and impact market growth.

Lancing device manufacturers are increasingly integrating custom vacuum technology into their devices to minimize pain during blood collection. Lancing devices utilizing this technology create shallow skin punctures without reaching the deeper pain-sensitive nerves, and blood is drawn up using the vacuum. For instance, the Genteel Lancing Device is a vacuum-based blood drawing lancing device designed to draw blood from capillaries and can be used on various body sites, not limited to fingers.

Major companies operating in the lancing devices and equipment market are developing innovative products such as disposable lancing devices to offer a more convenient and comfortable blood sugar monitoring experience. Disposable lancing devices are small, portable devices that puncture the skin and collect a small blood sample for glucose testing. For example, in August 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced Accu-Chek Pico, a fully disposable lancing device designed to simplify and enhance blood sugar monitoring, particularly for older adults with diabetes. It offers multiple benefits, including ease of use, gentleness on the skin, consistent lancing depths, and full disposability. It is also compatible with various Accu-Chek blood glucose meters, ensuring ease of use for individuals with diabetes.

In September 2021, B. Braun Melsungen AG, a German medical and pharmaceutical device company, acquired Sterinova Inc for an undisclosed sum. Sterinova will continue to operate as a separate subsidiary of B. Braun Melsungen AG. Sterinova Inc., based in Canada, specializes in the development, manufacturing, and distribution of ready-to-use sterile injectable products in syringes and premix bags.

Major companies operating in the lancing devices and equipment market include Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic PLC, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.

North America was the largest region in the global lancing devices and equipment market in 2023. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the lancing devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The lancing devices and equipment market consist of sales of safety lancets and standard lancets, flake lancets And fixed depth lancet. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.